The latest analyst updates for Babcock International Group centre on price targets that now span roughly £11.00 to £15.56 per share, compared with earlier levels such as £17.00 and £13.50. These shifts reflect a balance between upgraded ratings that lean more positive and reduced targets from cautious analysts who want clearer evidence on contract delivery and earnings before assigning higher valuations. As you read on, you will see how these changing targets fit into the broader Babcock...

↗️ Novartis (CH:NOVN): Shares in the Swiss pharmaceutical company climbed 2% after it returned to sales growth in the second quarter, driven by some of its top-selling drugs. ↗️ General Motors (GM): The automaker raised its earnings guidance.

Defense stocks jumped as investors bet the former defense secretary will oversee an increase in the department’s spending.

The United Kingdom’s independent financial regulator said the Big Four firm “failed to exercise” adequate professional skepticism in its audit of a British defense contractor.